迷幻商业化:新兴迷幻产业的广泛概述
Jacob S Aday1, Brian S Barnett2,3, Dan Grossman4
1Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, California, USA.
迷幻产业正在迅速扩张,这是由于精神病治疗的临床成功所推动的. 本综述探讨了其商业化,挑战和道德考虑,从胺和大麻行业中汲取教训.
科学领域:
- 制药行业 制药行业 制药行业
- 生物技术是生物技术.
- 精神病学研究精神病学研究
背景情况:
- 迷幻药辅助心理治疗在精神疾病临床试验中显示出有前途.
- 这导致了大量的财务投资,并在迷幻药物开发领域成立了众多公司.
- 迷幻产业现在是一个数十亿美元的市场.
研究的目的:
- 提供关于迷幻产业的全面概述.
- 详细介绍了迷幻药物商业化的历史和现状.
- 探索挑战,伦理考虑,以及类似行业的经验教训.
主要方法:
- 迷幻产业的历史分析.
- 检查当前的商业化趋势和公司重点领域.
- 识别对商业可行性的挑战和道德考虑.
- 与胺和大麻行业进行比较分析.
主要成果:
- 在2010年代末/2020年代初,对迷幻药物的金融投资激增.
- 关键的行业领域包括药物开发,新型配方,制造,治疗中心,消费品和辅助技术.
- 商业化面临着监管,成本和知识产权方面的障碍,以及关于不利影响,获取和土著互惠的伦理问题.
结论:
- 迷幻产业正在迅速起,取得了重大进展,还有挑战.
- 从胺和大麻行业的经验教训为监管批准,临床实施和政策提供指导.
- 商业化具有潜在的好处,但需要仔细导航道德和实际障碍.
更多相关视频
07:30HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice
Published on: July 9, 2016
11:14Rapid High-throughput Species Identification of Botanical Material Using Direct Analysis in Real Time High Resolution Mass Spectrometry
Published on: October 2, 2016
相关概念视频
An Overview of Psychoactive Drugs
Stimulants such as cocaine, amphetamines, and nicotine enhance brain activity, leading to increased alertness, attention, and energy. These drugs typically raise heart rate, blood pressure, and body temperature. While they can induce feelings of euphoria, their misuse can result in severe health...
Hallucinogens and Psychedelics
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
CNS Stimulants: Psychedelic Agents
Altered States of Awareness
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain...
Drug Discovery: Overview
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
